(Q34576932)

3 August 2017

1 reference

title

Polymorphisms in the ABC drug transporter gene MDR1. (English)

1 reference

3 August 2017

Brinkmann U

1

1 reference

3 August 2017

Eichelbaum M

series ordinal

2

1 reference

3 August 2017

publication date

1 January 2001

1 reference

The Pharmacogenomics Journal

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

59-64

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500001

3 August 2017

exact match

0 references

cites work

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

The multidrug resistance protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

P-glycoprotein and multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Isolation and expression of a complementary DNA that confers multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

A general pattern for substrate recognition by P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Clinical trials of P-glycoprotein reversal in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Multidrug resistance and the role of P-glycoprotein knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

The pharmacological role of P-glycoprotein in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

HIV-1 protease inhibitors and the MDR1 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Export pumps for glutathione S-conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

Influence of pharmacogenetics on drug disposition and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

inferred from DOI database lookup

7 January 2021

based on heuristic

P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

inferred from DOI database lookup

7 January 2021

based on heuristic

Both P-glycoprotein Nucleotide-binding Sites Are Catalytically Active

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.TPJ.6500001

1 reference

Dimensions Publication ID

3 August 2017

1030394125

0 references

1 reference